Literature DB >> 3579497

Familial rates of affective disorder. A report from the National Institute of Mental Health Collaborative Study.

N C Andreasen, J Rice, J Endicott, W Coryell, W M Grove, T Reich.   

Abstract

We examined familial rates of affective disorder and related illness in a cohort of 955 probands studied at five centers in the National Institute of Mental Health Collaborative Study of the Psychobiology of Depression: Boston, Chicago, Iowa City, New York, and St. Louis. Six hundred sixteen of these probands were entered into a family study, and 3423 of their first-degree relatives were evaluated. The probands were divided into five diagnostic groups: schizoaffective-bipolar (n = 37), schizoaffective-depressed (n = 18), bipolar I (n = 151), bipolar II (n = 76), and unipolar (n = 330). The relatives of bipolar I probands had a higher rate of bipolar I illness than the relatives of unipolar probands, but the relatives of unipolar probands did not have a higher rate of unipolar illness than the relatives of bipolar I probands. The relatives of probands with schizoaffective disorder, depressed subtype, had a higher rate of schizophrenia than the relatives of schizoaffective-bipolar probands, suggesting that bipolar schizoaffective disorder may be closer to pure affective disorder while schizoaffective depression may be closer to schizophrenia. An increase in bipolar II illness was also observed in the relatives of bipolar II probands. Overall, these data support the widely accepted distinction between bipolar and unipolar affective disorders.

Entities:  

Mesh:

Year:  1987        PMID: 3579497     DOI: 10.1001/archpsyc.1987.01800170083011

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  26 in total

1.  A longitudinal study of adolescent mental health service use.

Authors:  S P Cuffe; J L Waller; C L Addy; R E McKeown; K L Jackson; J Moloo; C Z Garrison
Journal:  J Behav Health Serv Res       Date:  2001-02       Impact factor: 1.505

2.  Subthreshold hypomanic symptoms in progression from unipolar major depression to bipolar disorder.

Authors:  Jess G Fiedorowicz; Jean Endicott; Andrew C Leon; David A Solomon; Martin B Keller; William H Coryell
Journal:  Am J Psychiatry       Date:  2010-11-15       Impact factor: 18.112

3.  Rethinking psychosis: the disadvantages of a dichotomous classification now outweigh the advantages.

Authors:  Nick Craddock; Michael J Owen
Journal:  World Psychiatry       Date:  2007-06       Impact factor: 49.548

Review 4.  Family, twin, and adoption studies of bipolar disease.

Authors:  Levi Taylor; Stephen V Faraone; Ming T Tsuang
Journal:  Curr Psychiatry Rep       Date:  2002-04       Impact factor: 5.285

Review 5.  Phenotype definition for genetic studies.

Authors:  J P Rice
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

6.  Continuing female predominance in depressive illness.

Authors:  A C Leon; G L Klerman; P Wickramaratne
Journal:  Am J Public Health       Date:  1993-05       Impact factor: 9.308

7.  Depression in the community: a comparison of treated and non-treated cases in two non-referred samples.

Authors:  W Maier; D Lichtermann; A Oehrlein; M Fickinger
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

8.  Genetic utility of broadly defined bipolar schizoaffective disorder as a diagnostic concept.

Authors:  M L Hamshere; E K Green; I R Jones; L Jones; V Moskvina; G Kirov; D Grozeva; I Nikolov; D Vukcevic; S Caesar; K Gordon-Smith; C Fraser; E Russell; G Breen; D St Clair; D A Collier; A H Young; I N Ferrier; A Farmer; P McGuffin; P A Holmans; M J Owen; M C O'Donovan; N Craddock
Journal:  Br J Psychiatry       Date:  2009-07       Impact factor: 9.319

Review 9.  The genetics of bipolar disorder.

Authors:  J H Barnett; J W Smoller
Journal:  Neuroscience       Date:  2009-04-07       Impact factor: 3.590

10.  Is risk-taking propensity a familial vulnerability factor for alcohol use? An examination in two independent samples.

Authors:  Stephanie M Gorka; Huiting Liu; Daniel Klein; Stacey B Daughters; Stewart A Shankman
Journal:  J Psychiatr Res       Date:  2015-06-11       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.